Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)

Pantelis Sarafidis; Charles J. Ferro; Enrique Morales; Alberto Ortiz; Jolanta Malyszko; Radovan Hojs; Khaled Khazim; Robert Ekart; Jose Valdivielso; Denis Fouque; Gérard M. London; Ziad Massy; Petro Ruggenenti; Esteban Porrini; Andrzej Wiecek; Carmine Zoccali; Francesca Mallamaci; Mads Hornum

doi:10.1093/ndt/gfz137

Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)

Pantelis Sarafidis, Charles J. Ferro, Enrique Morales, Alberto Ortiz, Jolanta Malyszko, Radovan Hojs, Khaled Khazim, Robert Ekart, Jose Valdivielso, Denis Fouque, Gérard M. London, Ziad Massy, Petro Ruggenenti, Esteban Porrini, Andrzej Wiecek, Carmine Zoccali, Francesca Mallamaci, Mads Hornum

Bar-Ilan University - Azrieli Faculty of Medicine

Research output: Contribution to journal › Comment/debate

9 Scopus citations

Abstract

In the original article, the words 'micro- or microalbuminuria' should have read 'micro- or macroalbuminuria' in the top boxes of Figures 4 and 5.

Original language	English
Pages (from-to)	1825
Number of pages	1
Journal	Nephrology Dialysis Transplantation
Volume	35
Issue number	10
DOIs	https://doi.org/10.1093/ndt/gfz137
State	Published - 1 Oct 2020

Bibliographical note

Publisher Copyright:
© 2020 Oxford University Press. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/ndt/gfz137

Fingerprint

Dive into the research topics of 'Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)'. Together they form a unique fingerprint.

Cite this

Sarafidis, P., Ferro, C. J., Morales, E., Ortiz, A., Malyszko, J., Hojs, R., Khazim, K., Ekart, R., Valdivielso, J., Fouque, D., London, G. M., Massy, Z., Ruggenenti, P., Porrini, E., Wiecek, A., Zoccali, C., Mallamaci, F., & Hornum, M. (2020). Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407). Nephrology Dialysis Transplantation, 35(10), 1825. https://doi.org/10.1093/ndt/gfz137

Sarafidis, Pantelis ; Ferro, Charles J. ; Morales, Enrique et al. / Erratum : SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407). In: Nephrology Dialysis Transplantation. 2020 ; Vol. 35, No. 10. pp. 1825.

@article{94d02f49f4b847cebd8bd825677f1afe,

title = "Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)",

abstract = "In the original article, the words 'micro- or microalbuminuria' should have read 'micro- or macroalbuminuria' in the top boxes of Figures 4 and 5.",

author = "Pantelis Sarafidis and Ferro, \{Charles J.\} and Enrique Morales and Alberto Ortiz and Jolanta Malyszko and Radovan Hojs and Khaled Khazim and Robert Ekart and Jose Valdivielso and Denis Fouque and London, \{G{\'e}rard M.\} and Ziad Massy and Petro Ruggenenti and Esteban Porrini and Andrzej Wiecek and Carmine Zoccali and Francesca Mallamaci and Mads Hornum",

year = "2020",

month = oct,

day = "1",

doi = "10.1093/ndt/gfz137",

language = "אנגלית",

volume = "35",

pages = "1825",

journal = "Nephrology Dialysis Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

number = "10",

}

Sarafidis, P, Ferro, CJ, Morales, E, Ortiz, A, Malyszko, J, Hojs, R, Khazim, K, Ekart, R, Valdivielso, J, Fouque, D, London, GM, Massy, Z, Ruggenenti, P, Porrini, E, Wiecek, A, Zoccali, C, Mallamaci, F & Hornum, M 2020, 'Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)', Nephrology Dialysis Transplantation, vol. 35, no. 10, pp. 1825. https://doi.org/10.1093/ndt/gfz137

Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407). / Sarafidis, Pantelis; Ferro, Charles J.; Morales, Enrique et al.
In: Nephrology Dialysis Transplantation, Vol. 35, No. 10, 01.10.2020, p. 1825.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407)

AU - Sarafidis, Pantelis

AU - Ferro, Charles J.

AU - Morales, Enrique

AU - Ortiz, Alberto

AU - Malyszko, Jolanta

AU - Hojs, Radovan

AU - Khazim, Khaled

AU - Ekart, Robert

AU - Valdivielso, Jose

AU - Fouque, Denis

AU - London, Gérard M.

AU - Massy, Ziad

AU - Ruggenenti, Petro

AU - Porrini, Esteban

AU - Wiecek, Andrzej

AU - Zoccali, Carmine

AU - Mallamaci, Francesca

AU - Hornum, Mads

PY - 2020/10/1

Y1 - 2020/10/1

N2 - In the original article, the words 'micro- or microalbuminuria' should have read 'micro- or macroalbuminuria' in the top boxes of Figures 4 and 5.

AB - In the original article, the words 'micro- or microalbuminuria' should have read 'micro- or macroalbuminuria' in the top boxes of Figures 4 and 5.

UR - https://www.scopus.com/pages/publications/85092680633

U2 - 10.1093/ndt/gfz137

DO - 10.1093/ndt/gfz137

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 31397476

AN - SCOPUS:85092680633

SN - 0931-0509

VL - 35

SP - 1825

JO - Nephrology Dialysis Transplantation

JF - Nephrology Dialysis Transplantation

IS - 10

ER -

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R et al. Erratum: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA (Nephrology Dialysis Transplantation (2019) (gfy407) DOI: 10.1093/NDT/gfy407). Nephrology Dialysis Transplantation. 2020 Oct 1;35(10):1825. doi: 10.1093/ndt/gfz137